{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:02:26Z","timestamp":1779721346647,"version":"3.53.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002489"],"award-info":[{"award-number":["UL1TR002489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011485","name":"North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018784","name":"Foundation of Hope for Research and Treatment of Mental Illness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jad.2025.119853","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T19:39:05Z","timestamp":1751917145000},"page":"119853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause"],"prefix":"10.1016","volume":"390","author":[{"given":"Erin","family":"Bondy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna","family":"Prim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rubinow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel S.","family":"Dichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal E.","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119853_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ogc.2018.07.007","article-title":"Depression during and after the perimenopause: impact of hormones, genetics, and environmental determinants of disease","volume":"45","author":"Bromberger","year":"2018","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.jad.2025.119853_bb0010","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1017\/S003329171100016X","article-title":"Major depression during and after the menopausal transition: study of Women\u2019s Health Across the Nation (SWAN)","volume":"41","author":"Bromberger","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2025.119853_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7180\/kmj.2017.32.1.5","article-title":"An overview of the clinical efficacy and safety of tissue selective estrogen complex: from the selective estrogens, menopause, and response to therapy (SMART) trials","volume":"32","author":"Chun","year":"2017","journal-title":"Kosin Med. J."},{"key":"10.1016\/j.jad.2025.119853_bb0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0889-8545(02)00013-X","article-title":"Perimenopausal use of reproductive hormones: effects on breast and endometrial cancer","volume":"29","author":"Collins","year":"2002","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.jad.2025.119853_bb0025","series-title":"Structured Clinical Interview for DSM-5\u2014Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV)","author":"First","year":"2015"},{"key":"10.1016\/j.jad.2025.119853_bb0030","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2147\/TCRM.S3476","article-title":"Bazedoxifene for the prevention of postmenopausal osteoporosis","volume":"4","author":"Gennari","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jad.2025.119853_bb0035","first-page":"178","article-title":"Conjugated estrogens\/bazedoxifene (Duavee)","volume":"40","author":"Goldberg","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.jad.2025.119853_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105418","article-title":"The role of estradiol fluctuation in the pathophysiology of perimenopausal depression: a hypothesis paper","volume":"133","author":"Gordon","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2025.119853_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5122(98)00025-5","article-title":"Constructing a standard climacteric scale","volume":"29","author":"Greene","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.jad.2025.119853_bb0050","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1210\/jc.2007-0066","article-title":"Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system","volume":"92","author":"Hale","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jad.2025.119853_bb0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/GME.0000000000002349","article-title":"The association of race, ethnicity, and socioeconomic status on the severity of menopause symptoms: a study of 68,864 women","volume":"31","author":"Kochersberger","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.jad.2025.119853_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103527","article-title":"Bazedoxifene plus conjugated estrogen to treat menopausal depression\u2014a pilot study","volume":"392","author":"Kulkarni","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2025.119853_bb0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/GME.0000000000001174","article-title":"Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations","volume":"25","author":"Maki","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.jad.2025.119853_bb0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2053369115599090","article-title":"Selective estrogen receptor modulators and the combination therapy conjugated estrogens\/bazedoxifene: a review of effects on the breast","volume":"21","author":"Pickar","year":"2015","journal-title":"Post Reprod. Health"},{"key":"10.1016\/j.jad.2025.119853_bb0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/GME.0000000000001095","article-title":"Tissue selective estrogen complex (TSEC): a review","volume":"25","author":"Pickar","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.jad.2025.119853_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/da.22391","article-title":"Efficacy of estradiol in perimenopausal depression: so much promise and so few answers","volume":"32","author":"Rubinow","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2025.119853_bb0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mob.2000.106004","article-title":"Estrogen replacement in perimenopause-related depression: a preliminary report","volume":"183","author":"Schmidt","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2025.119853_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/17512433.2014.893819","article-title":"Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy","volume":"7","author":"Sharifi","year":"2014","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119853_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100856","article-title":"Progesterone \u2013 Friend or foe?","volume":"59","author":"Sundstr\u00f6m-Poromaa","year":"2020","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jad.2025.119853_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2009.06.006","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","author":"Utian","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.jad.2025.119853_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.01.033","article-title":"Effects of estradiol administration on brain activation and anhedonia in perimenopausal women: a pharmaco-fMRI study","author":"Walsh","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119853_bb0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1037\/1040-3590.19.3.253","article-title":"Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS)","volume":"19","author":"Watson","year":"2007","journal-title":"Psychol. Assess."},{"issue":"22","key":"10.1016\/j.jad.2025.119853_bb0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/jwh.2012.3719","article-title":"The impact of menopausal symptoms on quality of life, productivity, and economic outcomes","volume":"2002","author":"Whiteley","year":"2013","journal-title":"J. Womens Health"},{"key":"10.1016\/j.jad.2025.119853_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal womenprincipal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725012959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725012959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:02:26Z","timestamp":1779717746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725012959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S0165032725012959"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119853","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119853"}}